Analytical Data
-
基因名
CDH22
- Application
-
别名
PB-cadherin; C20orf25; Pituitary and brain cadherin
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UJ99
-
表达区间
Trp64~Phe277
-
分子量
29kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CDH22, a member of the cadherin family, is a type of cell adhesion molecule that plays a crucial role in the regulation of cellular interactions and signaling. This protein is primarily expressed in the nervous system and has been implicated in neuronal development and synaptic function. The significance of CDH22 in synapse formation and maintenance highlights its potential role in neurodevelopmental disorders and neurodegenerative diseases. Recent studies suggest that alterations in CDH22 function may contribute to conditions such as autism spectrum disorders and schizophrenia. Given its involvement in critical brain functions, researchers are increasingly focused on characterizing CDH22 through recombinant protein techniques to better understand its structure, binding properties, and interaction with other cellular components. Producing recombinant CDH22 allows for detailed biochemical and biophysical analysis, which can aid in elucidating its mechanisms of action and potential therapeutic targets. The study of CDH22 not only advances our understanding of cadherin-mediated cell adhesion but also opens new avenues for exploring its role in various neurological conditions, making it a significant focus for future research in neurobiology and pharmacology.
